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Background: Exercise programmes are beneficial for cancer patients however evidence is limited in patients with
multiple myeloma (MM), a cancer that is characterised by osteolytic bone disease, giving rise to high levels of bone
morbidity including fractures and bone pain.
Methods: We conducted a single arm phase 2 study of an exercise programme (EP) as rehabilitation for treated
MM patients, to evaluate feasibility, effects on QOL and physiological parameters. Patients were given individualised
programmes, comprising stretching, aerobic and resistance exercises, carried out under supervision for 3 months
then at home for a further 3 months.
Results: Study uptake was high, 60 of 75 (80%) patients approached consented to the study. Screen failures
(11, due to fracture risk and disease relapse) and patient withdrawals (12) resulted in a final 37 patients enrolling on
the programme. These 37 patients demonstrated high attendance rates in the supervised classes (87%), and high
levels of adherence in home exercising (73%). Patients reported better QOL following the EP, with improvement in
FACT-G and Fatigue scores over time from baseline (p<0.01 for both, one-way repeated measures ANOVA) to 6
months. Upper and lower limb strength also improved on the EP, from baseline to 6 months (p<0.01 for both).
There were no adverse reactions.
Conclusions: An EP in MM patients is feasible and safe, with high attendance and adherence. Benefits in QOL,
fatigue and muscle strength await confirmation in randomized studies, prompting urgent evaluation of the benefits
of EP in the rehabilitation of MM patients.
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Multiple Myeloma (MM) is bone marrow cancer of
plasma cells that affects 15–20 per 100,000 people in the
Western world, with a peak incidence in the 7th decade
[1]. A unique and integral feature of this cancer is osteo-
lytic bone destruction, that is present in up to 70% of
patients at diagnosis [2]. Severe bone pain is a frequent
presenting symptom, and is a hallmark of lytic bone
lesions, which in many patients results in long bone and/
or vertebral compression fractures. Vertebral fractures* Correspondence: Kwee.yong@ucl.ac.uk
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distribution, and reproduction in any mediumlead to spinal deformity and instability, while spinal
surgery and fixation often leave patients with chronic pain
and reduced flexibility and mobility. Most patients initially
respond to treatment, which has traditionally comprised
chemotherapy and steroids +/− high dose therapy (HDT)
with autologous stem cell transplantation (ASCT) and
enter a plateau phase (remission) lasting a median of 3
years, before inevitable disease relapse. Although cure is
rare, new effective therapies are extending survival in this
cancer [3]. Despite enjoying longer remissions, many
patients continue to suffer with the sequelae of bone
destruction: persistent deformities, chronic pain, reduced
mobility and physical functioning, and fatigue. Together
with persisting toxicities of therapy such as neuropathyntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Groeneveldt et al. BMC Cancer 2013, 13:31 Page 2 of 10
http://www.biomedcentral.com/1471-2407/13/31and steroid induced myopathy, these prevent a return to
good personal and socio-economic functionality and
erode well-being and QOL [4-7].
The benefits of exercise in cancer patients both during
and after treatment are now well established, with
evidence supporting positive effects on cardiorespiratory
fitness and other physiological functions, including
muscle strength [8-10]. Additional benefits for psycho-
logical and emotional well-being, fatigue, anxiety, and
depression, although present, are less well supported in
terms of quantitative analysis. Most of the evidence
derives from studies of aerobic exercise in patients with
solid tumours (breast, prostate) while the literature on
patients with haematological cancers is less advanced.
Many studies in this area have focused on patients under-
going chemotherapy or haemopoietic stem cell transplan-
tation, with the aim of maintaining functional capacity,
body composition and body weight or muscle mass, all of
which parameters are known to decrease following inten-
sive chemotherapy +/− stem cell transplantation [11]. Many
of these studies used low-intensity or mixed exercise
[12,13] and few reported QOL benefits. A notable excep-
tion is the study by Courneya and colleagues, who exa-
mined the effect of a progressive aerobic training
programme on global QOL and physical functioning in
lymphoma patients, including some on chemotherapy [14].
These authors report significant improvements in patient
reported and objective measures of physical functioning.
There have been few studies of exercise in patients with
MM. Skeletal deformities and the risk of further fractures,
persistent pain and muscle wasting all render these patients
unattractive candidates for exercise intervention. One
recent study [15] examined the feasibility of exercise during
treatment in 14 MM patients undergoing chemotherapy
and HDT. Despite the small sample size, the authors found
an individually prescribed exercise programme (EP) to be
feasible and effective in maintaining body weight during
chemotherapy. The same group evaluated the effect of an
exercise programme in MM patients receiving erythro-
poietin whilst undergoing chemotherapy and ASCT [16].
Patients were randomized to a home-based exercise
programme or usual care. Results indicated a beneficial
effect on stem cell harvesting and blood product support.
Both studies involved patients undergoing active treatment,
however one randomised study, that included some
patients with myeloma, examined the benefits of an EP as
rehabilitation following a stem cell transplant [17]. The
authors found that a mixed EP improved physical functio-
ning but was without effect on QOL measures. Finally, an
observational study in MM patients reported that engaging
in even moderate exercise was associated with higher QOL
scores [18]. These preliminary reports suggest that MM
patients may benefit from regular exercise, and that EPs
may be feasible in this patient group.To provide further information on the feasibility,
safety and efficacy of EP as rehabilitation strategy, we
have carried out a pilot study of a tailored EP in treated
MM patients. The aim was to assess feasibility and
acceptability of an EP, and to obtain an estimate of the
effect size in patient-reported outcomes, in order to
power a future randomised study.
Methods
Institutional ethical approval was obtained from the joint
University College London and University College
London Hospitals (UCL/UCLH) committee on the
ethics of human research, Ref 06/Q0502/42, hence
the study has been performed in accordance with the
ethical standards laid down in the 1964 Declaration
of Helsinki. Eligible patients (in stable plateau phase
following chemotherapy and either off treatment or
on maintenance therapy) were recruited. Exclusion criteria
included spinal instability, risk of fracture, erythropoietin
treatment, unstable angina, or musculoskeletal disease
limiting mobility.
Patient recruitment and screening
Suitable patients were identified in multi-disciplinary
team meetings, or from outpatient clinics, and interested
patients were given a Patient Information Sheet (PIS) to
take home. Following informed consent, patients had a
skeletal survey, laboratory profile to confirm stable
disease and ECG where appropriate. Plain radiographs
were assessed for fracture risk in a multi-disciplinary
team meeting attended by a musculoskeletal radiologist,
clinical oncologist, myeloma specialists, physiotherapist
and clinical nurse specialists. Patients considered to be
at risk of fractures, e.g. with large lytic lesions of the long
bones or extensive lytic disease in the pelvis, underwent
cross-sectional imaging with CT or MRI and were
referred for surgery and/or radiotherapy. Patients who
passed screening underwent baseline assessments for all
study outcomes prior to starting on the EP.
Study design
This was a single arm pilot study aimed at recruiting 40
patients. The primary objective was to assess the feasibi-
lity (accrual rate, acceptability and adherence to the
programme) and safety (adverse events) of the EP. Secon-
dary objectives were to assess the effect of the programme
on overall QOL including fatigue, cardiorespiratory fitness,
body composition and muscle strength. All patients under-
took exercise training 3 times per week for 6 months. For
the first 3 months, one session per week was a group
session in the outpatient gym (supervised by the study
physiotherapist) while the other 2 were home-based. In the
subsequent 3 months, exercised sessions were home-based,
and subjects attended the gym just once a month. Home-
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with the study physiotherapist, who assessed all logbooks
and maintained the clinical report form for each patient.
Exercise programme
Each patient was given a programme based on their car-
diopulmonary fitness and exercise capacity; programmes
comprised stretching and mobility exercises, followed by
aerobic and resistance training. Each session comprised
both aerobic and resistance exercise training, with the
aim to improve both cardiorespiratory fitness and
muscle function. Aerobic exercise consisted of walking
or stationary cycling, starting at 15 minute bouts at an
intensity of 50% of heart rate reserve (HRR). During the
aerobic training sessions in the gym, patients used heart
rate monitors to maintain the prescribed heart rate and
therefore control exercise intensity. To support monito-
ring of correct exercise intensity at home, patients were
asked to report their rating of perceived exertion (RPE)
using the Borg Scale [19]. Patients were given scales to
take home, instructed in their use, and advised to work
to levels of exertion as determined under supervision.
Gradual progression in the exercise training was
achieved by alternately increasing exercise duration by 5
min and exercise intensity by 5% HRR every 4 weeks,
resulting an exercise session of 30 minutes duration at
an intensity of 60% HRR in the final 4 weeks of the
programme. All exercise programmes were prescribed
on an individual basis to ensure suitability and to promote
adherence to the programme.
Resistance exercises were individually tailored, targe-
ting the major muscle groups for upper and lower limbs.
Weight-lifting equipment, elastic exercise bands of varying
resistance and body-weight were used for strengthening.
When using the elastic exercise bands, the patient was
started on the lightest resistance (colour coded accor-
dingly). Likewise with the weight-lifting equipment, a low
weight was initially used. Patients performed sets of repe-
titions, starting at 3 sets of 10 repetitions. The repetitions
were progressed to 3 sets of 15 when deemed appropriate
by the physiotherapist. The resistance or weight was
increased when the patient felt that 3 sets of 15 at the
current weight or resistance was no longer challenging.
The repetitions then started again at 3 sets of 10 at the
new resistance level or weight. This was the format in
which the strength training was progressed, with the Borg
scale being used to guide the progression. Resistance exer-
cises were not modified for patients with vertebral frac-
tures that were stable, except where required, eg for spinal
deformity or lower back pain. In these cases, the position
for execution of an exercise was changed from standing to
sitting, or vice versa.
Each patient was given a demonstration of the exercises
by the physiotherapist, followed by a return demonstrationby the patient. Progression was achieved by increasing the
resistance or the number of repetitions performed on each
exercise. Each patient was given a booklet illustrating the
exercises, and a log book to record the frequency, intensity
and duration of the exercises, as well as their RPE on the
Borg scale. The log books were used to adjust the exercise
programme, as well as to assess adherence.
Study outcomes
Feasibility was assessed by the rate of uptake, the screen
pass rate, and the percentage of patients completing the
programme. Acceptability was assessed by attendance
rate in the gym-based classes, and by adherence to the
programme, as scored from the log-books that patients
brought in at each gym class. Adherence to the
programme, was scored from the log books as percentage
of exercise sessions completed over this period. Safety was
assessed by the rate of adverse reactions (AR), ie adverse
events (AE) that were clinically judged to be at least
possibly related to the intervention, eg. increased bone
pain, fractures or falls. Concomitant medication such as
analgesia regimens were recorded to monitor pain levels,
as a surrogate marker for AE’s.
Patient-rated and objective outcomes were assessed at
baseline, 4-weekly in the first 3 months, and at 6 months
from the start of the programme. Cancer-specific QOL
was assessed using the Functional Assessment of Cancer
Therapy General Cancer Scale (FACT-G). Fatigue was
assessed by the 13-item Fatigue Subscale of the FACIT
measurement system [20]. Baseline values were assessed
in comparison with a reference population [21]. An
increase in score indicates better QOL (FACT-G) and
less fatigue (FACIT-F). Clinically significant changes in
scores, termed Minimally Important Differences (MID)
have been defined for these scales [22]. The total FACT-G
and Fatigue scores have MIDs of 3–7, and 3–4 points
respectively. The Hospital Anxiety and Depression Scale
(HADS) was used to assess anxiety and depression [23].
Body mass, standing height, body composition (whole
body fat and lean tissue, assessed using Bioelectrical
Impedance Analysis), resting blood pressure and heart
rate were measured as part of baseline assessment of
cardiorespiratory fitness. Aerobic fitness was assessed
using an 8 minute submaximal single-stage treadmill
walking test [18]. This test allows for the estimation of
VO2max without the need for gas analysis or maximal
exertion on the part of the patient, and has been validated
as a method for assessing aerobic power by comparison
with direct (i.e. expired gas analysis) measurements of
VO2max [24]. For those patients who were unable to
perform this test (eg dependence on a walking aid, or
being unable to walk at a minimum speed of 2 miles
an hour), a submaximal bicycle ergometer (Tunturi E6)
and T-WARE W software (Tunturi Ltd, Turku, Finland)
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computer braked and progressed ergometer protocol with
increase in 25w every 2 minutes with HR monitoring. No
patients were able to sustain load increases to full VO2max
hence submaximal tests were used. Isometric hand grip
force, measured in kilograms, was assessed using a hand-
held dynamometer; the greatest force out of three measure-
ments from the right and left arm was taken, and the mean
of these was used. Knee extensor strength was measured
using a leg press, using 10 repetitions maximum (10RM),
and was defined as the maximum weight that can be lifted
just 10 times.
Focus groups
Three focus groups were held to explore patients’ views.
Twelve patients were invited and five men and five women
attended. Focus groups were organised when sufficient
patients were at a similar phase in the EP (weeks 6–12).
The focus groups were facilitated by a trained qualitative
researcher whom the patients had not met. A phenomeno-
logical approach was used [25] during the focus groups to
gain an understanding of how the exercise intervention had
impacted upon patients’ lives. Patients were asked how they
felt the exercise classes had affected their lifestyles. Focus
groups were recorded and transcribed. A thematic analysis
[26] was used to categorize recurrent and common themesFigure 1 Flow of patients through the study. 1 Seven patients declined
undertaking sufficient exercise in their lifestyle, or at their local gym, 2 beca
family or work commitments. 2 Two patients withdrew because of travellin
patients had disease progression, 4 withdrew because of family/work commfrom the data, using the software package NVIVO
(QSR 2006).
Analysis
All outcome measures were assessed for changes from
baseline. Assessments were performed every 4 weeks in the
first 3 months, to provide information on the timescale
over which effects were seen. A final assessment was
performed at 6 months from the start of the programme.
Planned analyses were carried out on data at 3 and 6
months, in comparison with baseline. Analyses included all
participants who started the EP, regardless of adherence or
attendance. Changes are summarized descriptively and
comparison with baseline was carried out using a
paired t-test (GraphPad PRISM). In addition, repeated
measures one-way ANOVA was used where appropriate
to evaluate changes over time. A p value of ≤0.05 is
regarded as significant.
Results
Study uptake, screening and progression through the
study
Patients were recruited from October 2006 to December
2007. Of 75 eligible patients approached, 15 patients
declined participation, largely due to personal or logistical
reasons (Figure 1). Figure 1 shows the flow of patientsbecause of travelling distance, 2 because they felt they were already
use they were not interested in the programme, and 4 because of
g distance, and 2 because of family/work commitments. 3Three
itments, and 1 with depression.
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due to fracture risk (7), disease relapse (5) and hyperten-
sion (1). One patient had prophylactic surgery after
screening and subsequently entered the programme, and
another patient was enrolled a year later after repeat im-
aging confirmed he was no longer at risk. A total of 49
patients entered the study. Four patients withdrew before
completing baseline screening tests. Of the 45 patients
who completed baseline assessments, a further 8 patients
withdrew prior to the start of the programme. All 37
patients who started on the programme completed 3
months, of these, only 28 were able to proceed to
the second 3 months because of funding constraints
but all of these completed the full 6 months.
Patient characteristics, attendance and adherence, and
safety
Of the 45 patients who completed baseline assessments,
approximately half of the patients had significant bone
disease with vertebral collapse and/or long bone fractures;
6 had undergone previous orthopaedic surgery and 11
received regular analgesia (Table 1). For the group as a
whole, total FACT-G scores (83.0±12.7, mean±SD, range
57 – 105) were comparable to reference means from a
normal healthy population in the US (80.1 ± 8.1) [21],
while Fatigue scores (35.8 ± 11.6, range 13–52) were below
the mean reference score (40.1 ± 10.4), ie patients experi-
enced more fatigue. The 8 patients who dropped out after
baseline assessments had similar FACT-G (80.5 ± 10.7),
and Fatigue (31.8 ± 12.3) scores (both NS compared
with the 37 patients who entered the programme). OfTable 1 Patient characteristics
CHARACTERISTIC
Age: Median (range) 61years (46–74 years)
Male 26 (58%)
Female 19 (42%)
Significant Bone disease1 23 (51%)
Time following completion of treatment 11months (median)
(range 3–149 months)
Previous ASCT2 42 (93%)
Previous orthopaedic surgery 6 (13%)
Current therapies
Maintenance treatment 9 (20%)
• Lenalidomide 1
• Interferon 2
• Thalidomide 6
Regular analgesia 11 (24%)
Details are given of patient characteristics for the 45 patients who completed
baseline screening.
1 with one or more of the following: bone pain, vertebral collapse, fractures.
2 autologous stem cell transplantation.these 37 patients, 20 had significant bone disease,
defined as lytic disease in more than one site, causing
persistent pain, fractures and/or requiring surgery. A
further 7 patients had moderate bone disease, defined
as lytic disease in only 1 site, including fracture and /or
surgery, but without persisting pain. Thus only 10 patients
had asymptomatic or no bone disease.
Attendance in the exercise classes over the first 3
months of the study was high (87 ± 11%, mean±SD). Five
patients failed to hand in their log books, but of the
remaining 32 patients, adherence to the programme was
86 ±15 %. In the second 3 months, patients attended the
outpatient gym only once every 4 weeks, and carried out
the rest of the exercise sessions at home. Of the 28
patients who took part in the second 3 months, 20
handed in their log books; inspection of these revealed
that adherence in the second 3 months was 73 ± 24%.
All 28 patients attended for their 4-weekly gym sessions
in the second 3 months (100% attendance). There were
no adverse reactions, in particular there were no falls, or
increases in bone pain in patients enrolled in the EP. On
the other hand, many patients reduced their use of ana-
lgesia, and of 11 patients taking regular analgesics, 7
reduced or discontinued their medication, including 4 of
the 6 patients on opioids.
Patient reported outcomes
Participation in the EP produced a marked improvement
in patient-reported QOL, with significant increase in
FACT-G scores (Table 2). For the 37 patients who com-
pleted 3 months on the EP, FACT-G scores improved
from a baseline of 83.6 ± 13.1 (mean±SD) to 87.7 ± 13.4
at 3 months (p < 0.001, paired t-test). Importantly, 28
patients improved on their FACT-G scores at 3 months,
and 22 of these achieved an MID (score change of > + 3).
A one-way repeated measures ANOVA determined that
FACT-G scores differed significantly between time
points (F = 9.71, p < .001) for the 28 patients who
completed 6 months. Post-hoc comparisons using the
Bonferroni correction showed a general improvement
over time, + 4.5 from baseline to 3 months (95% CI: -0.2
to 9.3, p = 0.062), + 7.3 from baseline to 6 months (95%
CI 2.7 to 11.9, p = 0.001), and + 2.8 from 3 months to
6 months (95% CI: -0.6 to 6.1, p = 0.141) (Figure 2).
Patients also reported less fatigue on the EP. This was
reflected in a significant improvement in fatigue scores
at 3 months, increasing from 37.4 ± 10.4 at baseline to
40.5 ± 9.0 (p < 0.01, t-test, Table 2). Seventeen of these
patients achieved an MID (score change of > + 3). For the
28 patients who completed 6 months, fatigue scores dif-
fered significantly over time points (F = 7.08, p = 0.002),
with a general improvement over time, +3.8 from baseline
to 3 months (95% CI −0.1 to 7.6, p = 0.056), + 4.3
from baseline to 6 months (95% CI: 1.5 to 7.1, p = 0.001)
Table 2 Changes from baseline FACT-G and Fatigue scores for 37 patients who completed 3 months (top) and for 28 of
these who completed 6 months (bottom)
BASELINE mean±SD
(range)
3 MONTHS mean±SD
(range)
CHANGE in mean P Number of patients who
Improved (MID) Worsened No Change
FACT-G 83.6 ± 13.1 87.7 ± 13.4 4.1 <0.001 28 9 0
n=37 (62–105) (53–108) (22)
FATIGUE 37.4 ± 10.4 40.5 ± 9.0 3.1 <0.01 25 9 3
n=37 (14–52) (19–52) (17)
BASELINE Mean±SD
(range)
6 MONTHS mean±SD
(range)
CHANGE in mean P n
Improved (MID) Worsened No Change
FACT-G 82.5 ± 12.1 89.8 ± 12.1 7.3 <0.001 23 3 2
n=28 (62–104) (69–107) (22)
FATIGUE 36.6 ± 10.6 41 ± 10.3 4.4 <0.001 23 4 1
n=28 (14–50) (16–52) (18)
Significance values for comparison of baseline scores with scores at 3 and 6 months are indicated (using paired t-test). Analysis of changes over time by one-way
repeated ANOVA is given in the Results section.
Figure 2 Effect of exercise study on selected patient reported and physiological outcomes. Changes in FACT-G (A), Fatigue (B), Upper
limb strength (C) and Lower limb strength (D) over time. Mean ± SD of each measure.
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Table 4 Changes in muscle strength, V02 max and fat-
free mass index
n=28 BASELINE 3 MONTHS 6 MONTHS
(mean ± SD) (mean ± SD) (mean ± SD)
Upper Limb Strength 32.3 ± 11.5 34.2 ± 10.7 35 ± 10.8
(Kilograms)
Lower Limb Strength 30.6 ± 16.8 37.6 ± 13.1 41 ± 12.7
(Kilograms)
Vo2 Max 27.8 ± 5 28.2 ± 4.5 28.1 ± 4.8
(Ml/Kg/Min)
Fat-Free Mass Index 18 ± 2.3 18 ± 2.5 18 ± 2.5
Scores at baseline, 3 and 6 months are given for the 28 patients who
completed 6 months on the programme.
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These changes are illustrated in Figure 2.
For the HADS scores, 9 of the 37 patients who com-
pleted 3 months had a baseline anxiety score of ≥ 8
(borderline or case), in 4 of these, their scores had
improved to 7 or less at 3 months. Six patients had a
baseline depression score of ≥ 8, and 2 had improved to
a score of 7 or less at 3 months. In the group that com-
pleted 6 months on the EP, anxiety scores did not
change (7 had scores of ≥ 8), while 2 out of 6 patients
with baseline depression scores of ≥ 8 had improved to 7
or less by 6 months. Table 3 gives the overall scores at
each time point.
Physiological outcomes
Upper limb strength improved significantly over time
points (F = 11.81, p < 0.001, one-way repeated measures
ANOVA), + 1.9 from baseline to 3 months (95% CI: 0.6
to 3.2, p = 0.003), + 2.8 from baseline to 6 months
(95% CI: 0.9 to 4.6, p = 0.002), and + 0.9 from 3 to 6
months (95% CI: -0.4 to 2.1, p = 0.277). Lower limb
strength also improved significantly over time (F = 12.01,
p < 0.001), + 7.0 from baseline to 3 months (95% CI: 1.2 to
12.9, p = 0.015), + 10.4 from baseline to 6 months (95%
CI: 4.0 to 16.8, p = 0.001), and + 3.4 from 3 to 6 months
(95% CI:- 0.9 to 7.7, p = 0.152). Figure 2 shows the time
frame of changes from baseline to 6 months in these 28
patients. There was no significant change in aerobic
capacity, as measured by VO2 max (F = 3.07, p = 0.057).
Table 4 summarizes the data for the 28 patients who
completed 6 months on the study.
Focus groups findings
Patients invited to the focus groups had been on the
programme for two to five months. Ten patients (5 men
and 5 women) attended three focus groups (one male,
one female and one mixed). Several themes were identi-
fied. One was the fear associated with the risk of bone
damage. The diagnosis of MM was itself frightening and
patients described how they were warned of the risk ofTable 3 HADS scores at baseline, 3 and 6 months
Normal Borderline Case
Anxiety
Baseline (n=37) 28 6 3
3 months (n=37) 30 5 2
6 months (n=28) 20 6 1
Depression
Baseline (n=37) 31 4 2
3 months (n=37) 31 4 2
6 months (n=28) 23 4 1
The total number of patients in each group is also indicated. (Normal = score 0–7,
Borderline = score 8–10, Case = score 11–21).bone fractures. Hence patients were unsure what exer-
cise was safe, many were not exercising before the study.
Patients described how their lives had been transformed
by the exercise intervention. They appreciated the
programmes were designed to suit individual needs, and
felt secure when advised and supervised by a trained
physiotherapist. A second theme was an increase in
confidence. Patients felt the programme had empowered
them, and improved their confidence in other areas of
their lives. They reported new activities outside the
home, including long walks or travelling abroad.
Another theme was the support that the patients gained
from contact with other MM sufferers. Observing how
fellow sufferers coped gave patients hope and enabled
them to talk about their future. Thus, the group exercise
experience seemed to influence their perception of
the future.
Discussion
The principal finding of this study is that a tailored EP is
safe and feasible in treated MM patients. Patient partici-
pating in the study demonstrated improvements in QOL
measures, particularly fatigue, and in muscle strength,
suggesting possible benefits of such an EP. Our study is
the first to systematically explore the feasibility and
benefits of a tailored EP in the rehabilitation of treated
MM patients. The high rate of uptake (80% of eligible
patients) compares favourably with a RCT in lymphoma
patients (26%, ref.14) and attests to the keenness of these
patients to engage in an EP, despite the perceived frailty
of their bones. The attrition rate (24%) was similar to
that reported for exercise programmes in other cancer
patient populations [27,28], and compares favourably with
one of the few reported studies in MM patients (42%,
Coleman et al.). Importantly, all patients who started on
the EP completed their planned 3, or 6 months. This,
together with the high attendance rates in the gym classes
(87% in first 3 months, 100% in second 3 months), indi-
cates the acceptability of the EP. Adherence was only
Groeneveldt et al. BMC Cancer 2013, 13:31 Page 8 of 10
http://www.biomedcentral.com/1471-2407/13/31assessable in patients who returned their logbooks
(71-86%), but levels were acceptable (72% and 86%),
and many patients testified that they performed the
EP at home, despite not filling in the log books. We
also confirmed that a tailored mixed EP is safe, in
that there were no AR’s.
In this era of MM therapy where new and effective
treatments are increasing remission rates and extending
survival [3], it is vital to focus on non-drug strategies
that will help to maximise wellbeing and QOL for survi-
vors. The inclusion of EP in rehabilitation is a novel
approach because hitherto, few clinicians have advised
their patients to engage in exercise, for fear of further
bone damage. On the other hand, their bone pathology
and skeletal complications mean that MM patients have
much to gain from exercising. Exercise improves bone
health, as shown by studies in women at risk of osteo-
porosis where weight bearing exercise increased bone
density [29]. Resistance exercise, by improving muscle
mass, improves strength and balance, reducing the rate
of falls which is a major risk factor for fractures [30].
Previous studies in this patient group have excluded
subjects with lytic bone disease, thus to the best of
our knowledge, this is the first study to demonstrate
that MM patients with significant bone disease are
able to exercise safely. Our results will make an important
contribution to the development of rehabilitation
programmes for these patients.
Due to their bone disease and generally older age,
(median age of MM survivors is 70 years) many MM
patients may not be suited to even moderately intensive
aerobic programmes, hence the inclusion of resistance
exercises is an important feature of the EP. Resistance
exercises can reduce fatigue, improve QOL and muscle
strength, and produce longer term improvements com-
pared with aerobic exercises [31]. Because of their bone
disease, patients were given individually tailored pro-
grammes, and attended supervised weekly exercise
sessions, factors that are likely to contribute to the safety
of the EP. Testimonies from the focus groups indicated
that patients found the supervised sessions reassuring,
gaining confidence to undertake new physical activities.
Because we found that some patients were unable to
perform the single stage submaximal treadmill walking
test, we used an alternative method of estimating
VO2max; future studies should standardise the test for
cardiorespiratory fitness. To improve on the logbook
return rate, patients may be offered incentives, and given
positive reinforcement in the form of follow-up telephone
calls from the physiotherapist.
Our study was designed as a single arm pilot study,
which clearly presents limitations when interpreting the
results. In particular, because subjects are compared only
to themselves previously, this design does not allow usto conclude that the improvements in patient reported
and objective outcomes are necessarily due to the inter-
vention. It is possible that patients would have experi-
enced improvements in these parameters over time. A
comparator group of patients, in a randomized study, is
required to answer this question. Some insights however,
may be derived from the focus groups. A focus group
is a more natural situation than an interview as the
participants share and compare experiences and opi-
nions. The results thus provide a powerful insight
into experiences, beliefs and attitudes [32,33]. Patients
reported benefits from meeting other MM sufferers,
such as increased confidence and hope for the future, and
thus patients may gain from engaging in physical activity
together. In an RCT of a group-based exercise programme
in breast cancer patients Mutrie and co-workers con-
cluded that some of the benefits observed derived from
the group experience [34].
A potentially important finding is the improvement in
fatigue levels following the EP. Because of the limitations
of a single arm study, we cannot conclude that this is
due to the EP, however, these findings warrant further
investigation. Fatigue is a prominent symptom in cancer
patients [35], and one of the widely reported benefits of
exercise training is a reduction in fatigue, however not
all studies have shown statistically significant effects
[8,34,36,37], and much of the evidence derives from
patients undergoing treatment. There is less information
in patients who have completed therapy, however a
single arm study reported that 32 cancer patients, after a
3-week programme of endurance and resistance exercise,
had improved physical performance and reduced fatigue
levels [38]. The mechanisms whereby exercise lessens
fatigue are not completely understood, but may relate in
part to improved sleep patterns [39,40]. Future work
could explore this mechanism by including a measure of
sleep. Reduced fatigue would particularly benefit this
older, more frail cancer group with bone morbidity as it
would lead to increased activity and functionality, with
attendant benefits on wellbeing and social functioning.
Conclusion
In conclusion, we demonstrate that a prescribed EP for
treated MM patients is feasible, acceptable and safe. The
findings in this single arm study await urgent confir-
mation in a randomised trial to evaluate the benefits of
exercise intervention as rehabilitation in these patients.
The longer term benefits of an EP, and the potential for
a sustained lifestyle change also need to be explored.
While the results of randomised trials are awaited, our
observations suggest that physicians can recommend
regular exercise to MM survivors, provided suitable scree-
ning measures are undertaken, and there is appropriate
input from trained physiotherapists.
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